Kumar Neil
BRIDGEBIO PHARMA INC · Chief Executive Officer
Kumar Neil is listed in filings as Chief Executive Officer at BRIDGEBIO PHARMA INC. This profile follows SEC Form 4 activity through Jun 8, 2026, including sale activity. Recent filings connect the profile to BRIDGEBIO PHARMA INC (BBIO) and Maze Therapeutics, Inc. (MAZE). The current snapshot covers public activity from Dec 8, 2025 to Jun 8, 2026. Reported amounts are shown as $304.5K to $572.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $304k4.4k shares | SellJun 5, 2026 | $68.96 | $81.46 | |
| $480k7.1k shares | SellJun 5, 2026 | $67.20 | $81.46 | |
| $305k4.4k shares | SellJun 5, 2026 | $68.96 | $81.46 | |
| $573k8.4k shares | SellJun 5, 2026 | $67.88 | $81.46 | |
| $480k7.1k shares | SellJun 5, 2026 | $67.20 | $81.46 |